SEQENS Competitors and Similar CompaniesClear all
SEQENS's competitors and similar companies include Dottikon, Sartorius Stedim Biotech, Cytiva and Finnadvance.
 SEQENS SEQENS (previously known as Novacap) is a company specializing in pharmaceutical synthesis and specialty ingredients. |  Dottikon Dottikon is a company that manufactures active pharmaceutical ingredients (APIs), intermediates, and performance chemicals. |  Sartorius Stedim Biotech Sartorius Stedim Biotech is a provider of products and services for the development, quality assurance, and production processes of the biopharmaceutical industry. |  Cytiva Cytiva (also known as Global Life Sciences Solutions USA, formerly GE Healthcare Life Sciences) is a company that provides technologies and services to support the development and manufacture of therapeutics. | ||
Founding Date | Founding Date 2003 | Founding Date 1913 | Founding Date 2007 | Founding Date 1968 | Founding Date 2019 |
Type | Type Private | Type Public | Type Public | Type Subsidiary | Type Private |
Tags | |||||
Locations | Locations Écully, FR HQ Saint Jean Sur Richelieu, CA Taizhou Shi, CN Zhenjiang, CN Turku, FI Bourgoin Jallieu, FR see more | Locations Dottikon, CH HQ Chicago, US | Locations Aubagne, FR HQ Jaipur, IN Bohemia, US | Locations Oulu, FI HQ | |
Employees | Employees 3,200903% increase | Employees 6781% increase | Employees 8,74616% increase | Employees 10,000 | Employees 176% decrease |
Twitter followers | Twitter followers 556 | Twitter followers 1 | Twitter followers N/A | Twitter followers 15.6 k | Twitter followers 552 |
Employee Rating | Employee Rating 3.3 | Employee Rating 3 | Employee Rating 3.9 | Employee Rating 4 | Employee Rating N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) CHF319.5m (FY, 2023) | Revenue (est.) €3.5b (FY, 2022) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods CHF91.4m (FY, 2023) | Cost of goods €1.5b (FY, 2022) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit CHF230.9m (FY, 2023) | Gross profit €2b (FY, 2022) | Gross profit N/A | Gross profit N/A |
Net income | Net income N/A | Net income CHF87.7m (FY, 2023) | Net income €879.9m (FY, 2022) | Net income N/A | Net income N/A |
For sources of this data, please see the company profile
View Company Profiles
Dottikon
HQ
Dottikon, CH
Employees
678↑ 1% increase
Dottikon is a company that manufactures active pharmaceutical ingredients (APIs), intermediates, and performance chemicals.
View companySartorius Stedim Biotech
HQ
Aubagne, FR
Employees
8,746↑ 16% increase
Sartorius Stedim Biotech is a provider of products and services for the development, quality assurance, and production processes of the biopharmaceutical industry.
View companyCytiva
HQ
Marlborough, US
Cytiva (also known as Global Life Sciences Solutions USA, formerly GE Healthcare Life Sciences) is a company that provides technologies and services to support the development and manufacture of therapeutics.
View company
Finnadvance
HQ
Oulu, FI
Employees
17↓ 6% decrease
Finnadvance is a company providing microfluidics and microtechnology solutions.
View company